<MedlineCitation Status="Completed">
<MedlineID>10011151</MedlineID>
<PMID>420707</PMID>
<DateCreated>
<Year>1979</Year>
<Month>04</Month>
<Day>26</Day>
</DateCreated>
<DateCompleted>
<Year>1979</Year>
<Month>04</Month>
<Day>26</Day>
</DateCompleted>
<DateRevised>
<Year>2000</Year>
<Month>12</Month>
<Day>18</Day>
</DateRevised>
<Article>
<Journal>
<ISSN>0004-3591</ISSN>
<JournalIssue>
<Volume>22</Volume>
<Issue>2</Issue>
<PubDate>
<Year>1979</Year>
<Month>Feb</Month>
</PubDate>
</JournalIssue>
</Journal>
<ArticleTitle>Cartilage proteoglycan alterations in an experimentally induced model of rabbit osteoarthritis.</ArticleTitle>
<Pagination>
<MedlinePgn>155-63</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>Size distribution of cartilage proteoglycans (PG) extracted from control and osteoarthritic rabbit knees after partial meniscectomy was analyzed. In normal control knees, about 30% of PG molecules were in aggregate form and average sedimentation constant was 60S. No aggregates were found in osteoarthritic cartilage, whether ulcer, rim about ulcer, or distant normal-appearing cartilage was examined. Weight average sedimentation constants for PG subunits were similar to controls, 15S. Up to 70% of guanidinium-extractable PG could be extracted from osteoarthritic cartilage by using 0.5M guanidine HC1 (GuHCl); sedimentation characteristics of extracted PG were similar to those using 4.0M GuHCl. Absence of aggregates is consistent with a disorder of link protein, hyaluronic acid, or PG subunit hyaluronic acid binding sites. Absence of subunit degradation was an enexpected finding. The demonstrated ability of 0.5 M GuHCl to extract large amounts of PG from osteoarthritic cartilage will allow study of cartilage proteoglycans in their native nondissociated state.</AbstractText>
</Abstract>
<AuthorList>
<Author>
<LastName>Moskowitz</LastName>
<ForeName>R W</ForeName>
<Initials>RW</Initials>
</Author>
<Author>
<LastName>Howell</LastName>
<ForeName>D S</ForeName>
<Initials>DS</Initials>
</Author>
<Author>
<LastName>Goldberg</LastName>
<ForeName>V M</ForeName>
<Initials>VM</Initials>
</Author>
<Author>
<LastName>Muniz</LastName>
<ForeName>O</ForeName>
<Initials>O</Initials>
</Author>
<Author>
<LastName>Pita</LastName>
<ForeName>J C</ForeName>
<Initials>JC</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>UNITED STATES</Country>
<MedlineTA>Arthritis Rheum</MedlineTA>
<NlmUniqueID>0370605</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Guanidines</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Hexuronic Acids</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Proteoglycans</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName>Animal</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName>Cartilage, Articular</DescriptorName>
<QualifierName MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName>Guanidines</DescriptorName>
<QualifierName>diagnostic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName>Hexuronic Acids</DescriptorName>
<QualifierName>isolation &#38; purification</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName>Knee Joint</DescriptorName>
<QualifierName>metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName>Methods</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName>Osteoarthritis</DescriptorName>
<QualifierName MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName>Proteoglycans</DescriptorName>
<QualifierName>isolation &#38; purification</QualifierName>
<QualifierName MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName>Rabbits</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName>Support, U.S. Gov't, Non-P.H.S.</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName>Support, U.S. Gov't, P.H.S.</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName>Ulcer</DescriptorName>
<QualifierName>metabolism</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
